DBV Technologies (DBVT) Cash from Investing Activities (QoQ) (2020 - 2026)
DBV Technologies (DBVT) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
DBV Technologies |
7.53 Bn |
7.30 Bn |
-3.90 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
58.04% |
| Dec 31, 2025 |
-196.68% |
| Sep 30, 2025 |
-1,753.85% |
| Jun 30, 2025 |
96.75% |
| Mar 31, 2025 |
-150.44% |
| Dec 31, 2024 |
827.52% |
| Sep 30, 2024 |
-115.77% |
| Jun 30, 2024 |
132.41% |
| Mar 31, 2024 |
-1,040.11% |
| Dec 31, 2023 |
41.93% |
| Sep 30, 2023 |
5.57% |
| Jun 30, 2023 |
-911.90% |
| Mar 31, 2023 |
223.53% |
| Dec 31, 2022 |
-122.37% |
| Sep 30, 2022 |
166.38% |
| Jun 30, 2022 |
-2,181.82% |
| Mar 31, 2022 |
102.32% |
| Dec 31, 2021 |
-977.78% |
| Sep 30, 2021 |
-68.60% |
| Jun 30, 2021 |
192.97% |
